Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Tessari Eben exercised options for 5,975 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Jan 15 to Apr 1, 2026 · Filed Apr 3, 2026
From Jan 15 to Apr 1, 2026, Tessari Eben (CHIEF STRATEGY OFFICER) exercised options for 5,975 Kiniksa Pharmaceuticals International, Plc shares, leaving 21,250 shares. Filed Apr 3, 2026 (Form 4).
- Options exercised
- 5,975 shares
- Holding after
- 21,250 shares
- Trading plan
- No
- Role
- CHIEF STRATEGY OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Class A Ordinary Share | Award | 365 | US$24.16 | 17,031 | Direct |
| Apr 1, 2026 | Class A Ordinary Share | Option exercise | 5,975 | 23,006 | Direct | |
| Apr 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 1,756 | US$48.13 | 21,250 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Tessari Eben
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Tessari Eben · Apr 8, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026